-
1
-
-
0035865285
-
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk
-
Brekelmans C., Seynaeve C., Bartels C., et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19 (2001) 924
-
(2001)
J Clin Oncol
, vol.19
, pp. 924
-
-
Brekelmans, C.1
Seynaeve, C.2
Bartels, C.3
-
2
-
-
0030933762
-
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA-2
-
Sharan S., Morimatsu M., Albrecht U., et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA-2. Nature 386 (1997) 804-810
-
(1997)
Nature
, vol.386
, pp. 804-810
-
-
Sharan, S.1
Morimatsu, M.2
Albrecht, U.3
-
3
-
-
0031472370
-
Association of BRCA-1 with Rad51 in mitotic and meiotic cells
-
Scully R., Chen J., Plug A., et al. Association of BRCA-1 with Rad51 in mitotic and meiotic cells. Cell 88 (1997) 265-275
-
(1997)
Cell
, vol.88
, pp. 265-275
-
-
Scully, R.1
Chen, J.2
Plug, A.3
-
4
-
-
33645983925
-
Screening mammography and risk of breast cancer in BCRA1 and BCRA2 mutation carriers: a case-control study
-
Narod S., Lubinski J., Ghadirian P., et al. Screening mammography and risk of breast cancer in BCRA1 and BCRA2 mutation carriers: a case-control study. Lancet Oncol 7 (2006) 402-406
-
(2006)
Lancet Oncol
, vol.7
, pp. 402-406
-
-
Narod, S.1
Lubinski, J.2
Ghadirian, P.3
-
5
-
-
0142180096
-
Roles of radiation dose, chemotherapy and hormonal factors in breast cancer following Hodgkin's disease
-
Narod S., and Lubinski J. Roles of radiation dose, chemotherapy and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95 (2003) 1552
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1552
-
-
Narod, S.1
Lubinski, J.2
-
6
-
-
0034306318
-
Effect of radiotherapy after breast conserving treatment in women with breast cancer and germline BRCA1/2 mutations
-
Pierce L., Strawderman M., Narod S., et al. Effect of radiotherapy after breast conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18 (2000) 3360-3369
-
(2000)
J Clin Oncol
, vol.18
, pp. 3360-3369
-
-
Pierce, L.1
Strawderman, M.2
Narod, S.3
-
7
-
-
0032873622
-
Radiation-induced sarcoma of the breast following conservation surgery
-
Benson J., and Osborne M. Radiation-induced sarcoma of the breast following conservation surgery. Breast Cancer Res Treat 54 (1999) 293
-
(1999)
Breast Cancer Res Treat
, vol.54
, pp. 293
-
-
Benson, J.1
Osborne, M.2
-
8
-
-
0027535978
-
Breast cancer after treatment of Hodgkin's disease
-
Hancock S., Tucker M., and Hoppe R. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85 (1993) 25-31
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 25-31
-
-
Hancock, S.1
Tucker, M.2
Hoppe, R.3
-
9
-
-
2342446497
-
The development of interval breast malignancies in patients with BRCA mutations
-
Komenaka I., Ditkof B., Joseph K., et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 100 (2004) 2079-2083
-
(2004)
Cancer
, vol.100
, pp. 2079-2083
-
-
Komenaka, I.1
Ditkof, B.2
Joseph, K.3
-
10
-
-
19744380352
-
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
-
MARIBS study group
-
MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005) 1769-1778
-
(2005)
Lancet
, vol.365
, pp. 1769-1778
-
-
-
11
-
-
19744376307
-
MRI surveillance for hereditary breast cancer
-
Warner E., and Causer P. MRI surveillance for hereditary breast cancer. Lancet 365 (2005) 1747-1749
-
(2005)
Lancet
, vol.365
, pp. 1747-1749
-
-
Warner, E.1
Causer, P.2
-
12
-
-
0033552904
-
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
-
Hartmann L., Schaid D., Woods J., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340 (1999) 77-84
-
(1999)
N Engl J Med
, vol.340
, pp. 77-84
-
-
Hartmann, L.1
Schaid, D.2
Woods, J.3
-
13
-
-
19744368081
-
-
National Comprehensive Cancer Network (accessed April 10, 2006)
-
National Comprehensive Cancer Network. Genetic/familial/high-risk assessment: breast and ovarian (2005). http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf (accessed April 10, 2006)
-
(2005)
Genetic/familial/high-risk assessment: breast and ovarian
-
-
|